JKMG Group is a Dallas-based healthcare business brokerage, established in 2014, that handles healthcare M&A on an asset-sale basis. The desk represents owners selling physician practices, pharmacies, labs, agencies, and senior-care businesses, and buyers acquiring them, across Dallas-Fort Worth, Texas, and other U.S. markets by engagement. These are the questions owners and buyers ask before a first call.
It depends on normalized EBITDA or owner earnings, revenue, specialty, payer mix, provider dependence, growth, regulatory risk, and current buyer demand, not one generic multiple. The free indicative range on this site takes about sixty seconds, and a senior-reviewed estimate follows within one business day. You can run either before deciding anything about a sale.
Physician practices in primary care, internal medicine, cardiology, podiatry, and optometry; pharmacies; laboratories, including molecular diagnostics and toxicology; imaging centers; hospice and home health agencies; senior care, including assisted living; DME companies; and healthcare technology businesses. Current mandates run from roughly $200K to $20M in transaction size.
No. Owners often reach the desk two to three years ahead of a planned retirement, which leaves time to clean up financial reporting, reduce owner dependence, and fix operating issues before a buyer sees the numbers. A first conversation is confidential and carries no obligation.
Roughly a year end to end. Once a mandate is live, sell-side processes in physician practice and pharmacy typically run six to ten months from intake to close. The slowest step is almost always how quickly the seller can produce diligence items.
Yes. Many healthcare transactions include a transition period or continued employment for the selling physician or owner. The terms depend on the buyer, your objectives, compensation, and what the practice needs to keep running.
Often, yes. A recapitalization lets an owner take partial liquidity while keeping a stake and continuing to operate. JKMG runs full-sale and recap engagements and lays out both before you choose.
No. The buyer pool for a healthcare business includes individual physicians, healthcare operators, regional groups, strategic acquirers, family offices, and private-equity-backed platforms. The desk maps that universe to your objectives instead of defaulting to one buyer type.
Continuity is usually central to the deal. Buyers tend to keep experienced clinical and administrative staff because continuity protects value, and transition planning covers provider coverage, patient communication, medical records, payer and referral relationships, and your post-closing role. Where the owner is the main provider, the first recommendation is to hire an employed provider who will stay on after the sale.
Sustainable profitability on clean financials, a recurring patient panel, a favorable payer mix, provider coverage beyond the owner, diversified referral sources, compliant operations, capable management, and room to add providers or ancillary services. Heavy owner dependence works against you.
Both, depending on size. Smaller owner-operated practices are often evaluated on revenue and owner earnings; larger businesses on normalized EBITDA, meaning earnings adjusted for nonrecurring, discretionary, and owner-specific expenses that would not continue under new ownership. A proper valuation weighs several methods, never one formula.
Tax returns, profit-and-loss statements, balance sheets, payroll and provider compensation, payer mix, production and collections reports, accounts receivable, leases, licenses, contracts, and compliance records. The exact diligence package depends on the type of healthcare business, and having it ready early is the single biggest time saver.
Through a targeted buyer universe built for each mandate: JKMG's own buy-side clients, strategic acquirers, sponsors and platform companies, healthcare operators, and other qualified buyers, reached through direct outreach. The goal is a controlled process, not a public posting that waits for inquiries.
A letter of intent, or LOI, sets out the principal terms a buyer proposes: purchase price, transaction structure, financing, working capital, seller transition, exclusivity, diligence scope, and closing conditions. Signing one is what moves the process into confirmatory diligence.
Not always. Read the whole structure: cash at closing, financing contingencies, earnouts, rollover equity, working-capital targets, employment terms, real estate, and indemnification. Two offers with the same headline price can leave you with very different outcomes.
Confirmatory diligence, legal documentation, financing, and any licensing or regulatory steps, then closing. JKMG coordinates all of it through close and into transition planning; the work does not end when an offer lands.
Yes. The desk runs buy-side engagements, including platform searches and add-on acquisitions, for healthcare operators, independent physicians, family offices, and sponsor-backed groups. It can also return an indicative valuation range on a target you are already looking at.
Listings are anonymized. Request the teaser from any mandate; financials, location detail, and process phase are released to qualified buyers after a signed NDA.
Healthcare only, run from an operator's seat. The Founder built and ran healthcare companies before brokering them, and every engagement stays senior-led from preparation through buyer outreach, negotiation, diligence, and closing. Inquiries go to the CEO and Founder first, not to associates.
No. JKMG is based in Dallas with most of its activity in Dallas-Fort Worth and North Texas, and has run engagements across six states, including current mandates outside Texas.
Asset sales. JKMG Group does not broker securities, and nothing on this site is an offer to sell securities.
Confidential by default. Opportunities go to market as de-identified one-page teasers with no practice name, and financials, location detail, and identity are released only to qualified buyers after a signed NDA. Your staff do not need to know a process is underway.
Get a free indicative range in about sixty seconds. A senior-reviewed estimate follows within one business day.
Valuation estimate →Every inquiry routes to the CEO and Founder first. Confidential by default, NDA before data.
Route to desk →